Skip to main content
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia.
Assessment of a modified MINDS-based protocol for management of alcohol withdrawal syndrome on an inpatient medical service.
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
Combining Antidepressants with ß-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction.
Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
Dose-escalation study of ICA-17043 in patients with sickle cell disease.
Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.